Philip D. Poorvu
- Reproductive Medicine top 5%
- Oncology top 10%
- Cancer Risks and Factors 8
- Cancer survivorship and care 6
- Cancer Research top 10%
- Breast Cancer Treatment Studies 12
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 4
-
- Reproductive Biology and Fertility 7
-
- Advanced Breast Cancer Therapies 9
-
- BRCA gene mutations in cancer 4
-
- Childhood Cancer Survivors' Quality of Life 4
- Co-authors
- Ann H. PartridgeShoshana M. RosenbergKathryn J. RuddyVirginia F. BorgesSteven E. ComeJeffrey PeppercornRulla M. TamimiLidia Schapira
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Philip D. Poorvu
40 papers receiving 706 citations
Peers
Comparison fields: 5 of 76
- Reproductive Medicine 145
- Oncology 345
- Cancer Research 179
- Obstetrics and Gynecology 66
- Public Health, Environmental and Occupational Health 196
Countries citing papers authored by Philip D. Poorvu
This map shows the geographic impact of Philip D. Poorvu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Poorvu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Poorvu more than expected).
Fields of papers citing papers by Philip D. Poorvu
This network shows the impact of papers produced by Philip D. Poorvu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Poorvu. The network helps show where Philip D. Poorvu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip D. Poorvu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 19 | |
| 14 | 2021 | 32 | |
| 15 | 2021 | 69 | |
| 16 | 2021 | 27 | |
| 17 | 2020 | 23 | |
| 18 | 2019 | 48 | |
| 19 | 2013 | 17 | |
| 20 | 2012 | 54 |
About Philip D. Poorvu
Philip D. Poorvu is a scholar working on Oncology, Cancer Research and Reproductive Medicine, having authored 44 papers that have together received 718 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (9 papers), Cancer Risks and Factors (8 papers), Reproductive Biology and Fertility (7 papers), Cancer survivorship and care (6 papers), BRCA gene mutations in cancer (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Endometrial and Cervical Cancer Treatments (4 papers). The work is most often cited by research in Reproductive Medicine (145 citations), Oncology (345 citations) and Cancer Research (179 citations). Philip D. Poorvu has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Ann H. Partridge, Shoshana M. Rosenberg, Kathryn J. Ruddy, Virginia F. Borges, Steven E. Come, Jeffrey Peppercorn, Rulla M. Tamimi, Lidia Schapira, Shari Gelber and Elizabeth S. Ginsburg. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.